ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

HIK Hikma Pharmaceuticals Plc

1,934.00
-20.00 (-1.02%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -20.00 -1.02% 1,934.00 1,925.00 1,926.00 1,956.00 1,919.00 1,955.00 145,039 16:35:28
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.88B 192M 0.8653 22.25 4.34B
Hikma Pharmaceuticals Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HIK. The last closing price for Hikma Pharmaceuticals was 1,954p. Over the last year, Hikma Pharmaceuticals shares have traded in a share price range of 1,722.00p to 2,165.00p.

Hikma Pharmaceuticals currently has 221,886,453 shares in issue. The market capitalisation of Hikma Pharmaceuticals is £4.34 billion. Hikma Pharmaceuticals has a price to earnings ratio (PE ratio) of 22.25.

Hikma Pharmaceuticals Share Discussion Threads

Showing 1576 to 1599 of 1875 messages
Chat Pages: 75  74  73  72  71  70  69  68  67  66  65  64  Older
DateSubjectAuthorDiscuss
05/5/2022
15:36
P/E ~ 11 for a pharmaceutical company with a solid balance sheet with growth areas seems very low.
justiceforthemany
05/5/2022
12:21
Wrong yet again Monty
I must say you are a very useful contra bellwether

phillis
05/5/2022
10:53
10% share price fall seems very harsh for these revenues moving out perhaps 2-3 months!
adamb1978
05/5/2022
10:02
Serial disappointment. The last one was About the GSK drug thingee.The CEO is well regarded so we'll see what happens
robertball
05/5/2022
08:39
Market always overdo it on the downside and upside.Like I said never ever thought I would see forecast p.e 10.7 for Hikma.
montyhedge
05/5/2022
08:25
While sentiment is generally against this stock, any little wobble will knock the price down far more than an equivalent bit of good news will raise it. Sentiment will turn whenever it deigns to.
mjneish
05/5/2022
08:24
Looks to be a bit of a timing issue - so imo the fall looks overly harsh.
But who knows - this share has been hammered since the end of last year.
Suet

suetballs
05/5/2022
08:07
Cant fall much further surely
scepticalinvestor
05/5/2022
08:07
Added at 1660
scepticalinvestor
05/5/2022
08:01
Not really
robertball
05/5/2022
07:53
Good grief, basket case
scepticalinvestor
05/5/2022
07:08
Never thought I would see Hikma forecast p.e 10.7. Well at least more shares for them in the buybacks.
montyhedge
05/5/2022
07:07
The FT just said that share price subdues due to slow generics.
robertball
05/5/2022
06:53
Nope sorry that was wrong

It was unchanged

netcurtains
05/5/2022
06:46
Lower generics guidance for 2022 this am - not good with the share price already severely depressed.
Suet

suetballs
04/5/2022
07:25
Do we know the reason for recent big falls?
What did the FT comment say?

Thanks for any info.

Cheers Net.

netcurtains
30/4/2022
07:06
As per FT comment today
robertball
29/4/2022
15:20
Monty: Thanks for pointing that out. Cheers Net!
netcurtains
29/4/2022
14:23
It will bounce, in April 2020 shares were 1767p April 2020 trading update said generic margins 13% to 18% shares were 2700p by the Oct 2020.This April trading update generic margins 23% to 25% growth 8% to 9% and shares fall 7.2%.
montyhedge
29/4/2022
13:10
blue59: Well, if you know different, you're not telling anyone.
I suspect no one actually knows.

It will probably either recover quickly (as it has in the past) or some further news will come out explaining it all.

netcurtains
29/4/2022
12:37
Down 7%, I thought quite good, they said strong cash generation. All in line, shows how much I know, lol
montyhedge
29/4/2022
10:16
Must admit seems strange, unless a fund dumping, but look at the shares in the buyback 100p cheaper.
montyhedge
29/4/2022
10:05
Was it just a HIK up?
netcurtains
29/4/2022
08:02
Why is a PE ratio of about 12, with a dividend, with share buyback, and growing at 7% per annum considered bad news?

What have I missed?

netcurtains
Chat Pages: 75  74  73  72  71  70  69  68  67  66  65  64  Older